Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4453791000168118 | tafamidis meglumine 20 mg capsule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4453801000168117 | tafamidis meglumine 20 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tafamidis meglumine 20 mg capsule | Is a | tafamidis | true | Inferred relationship | Some | ||
| tafamidis meglumine 20 mg capsule | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| tafamidis meglumine 20 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| tafamidis meglumine 20 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 2129681589 | |
| tafamidis meglumine 20 mg capsule | has intended active ingredient | tafamidis | true | Inferred relationship | Some | 1425475300 | |
| tafamidis meglumine 20 mg capsule | has Australian BoSS | tafamidis meglumine | true | Inferred relationship | Some | 1425475300 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vyndaqel 20 mg capsule | Is a | True | tafamidis meglumine 20 mg capsule | Inferred relationship | Some | |
| tafamidis meglumine 20 mg capsule, 30 | has MPUU | True | tafamidis meglumine 20 mg capsule | Inferred relationship | Some | 738652600 |
Reference Sets
Medicinal product unit of use reference set
FHIR